6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
Open accessAbstract
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The common recommendation for hypoglycemia treatment (15 g simple carbohydrates, recheck in 15 min) was predominantly based on expert opinion and two small-sized studies of intravenous insulin-induced hypoglycemia in people living with type 1 diabetes mellitus.
“Remarkably, this “15 grams/15 minutes” treatment is solely based on expert opinion, and two frequently-referenced, small-sized studies of intravenous insulin-induced hypoglycemia in people living with T1D [3–7].”
From Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus (2026) · cites this paper as [4]
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredThe majority of non-severe hypoglycemia events are treated by the person living with diabetes with oral ingestion of simple carbohydrates to rapidly raise blood glucose levels.
“The majority of non-severe hypoglycemia events are treated by the person living with diabetes with oral ingestion of simple carbohydrates to rapidly raise the blood glucose levels [3–5].”
From Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus (2026) · cites this paper as [4]
The Hypoglycemia Treatment section recommends that individuals treat hypoglycemia with fast-acting carbohydrates and says glucose-containing carbohydrates raise blood glucose. The Hypoglycemia Definitions and Event Rates section says level 1 and 2 events make up the vast majority of hypoglycemic events. Neither section establishes that the majority of non-severe events are actually self-treated with oral carbohydrates; the treatment passage gives a recommendation, not an observed rate. (LLM, conf=0.86)
Experimental — accuracy not yet measuredLack of timely treatment of Level 1 hypoglycemia leads to Level 2 hypoglycemia.
“Lack to timely treatment will then lead to Level 2 hypoglycemia (glucose below 3.0 mmol/L), also known as moderate hypoglycemia, when the person living with diabetes experiences neuroglycopenic symptoms such as confusion, drowsiness, slurred speech, and weakness [3–5].”
From Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus (2026) · cites this paper as [4]
The paper’s “Hypoglycemia Definitions and Event Rates” section defines level 2 as glucose below 3.0 mmol/L, where neuroglycopenic symptoms begin. “Hypoglycemia Treatment” advises treating at the level 1 alert threshold of 3.9 mmol/L or less. It does not say that failure to treat level 1 will necessarily lead to level 2. (LLM, conf=0.84)
Experimental — accuracy not yet measuredThe 15 g/15 min recommendation has been widespread in clinical guidelines for the past few decades and has been suggested for both people living with T2D and type 1 diabetes mellitus.
“This recommendation has been widespread in clinical guidelines for the past few decades and has been suggested for both people living with T2D and type 1 diabetes mellitus (T1D) [3–5].”
From Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus (2026) · cites this paper as [4]
The Hypoglycemia Treatment section recommends 15 g of carbohydrate for most individuals with diabetes and a glucose check 15 minutes later; the paper discusses hypoglycemia in both type 1 and type 2 diabetes. It does not establish that this recommendation has been widespread across clinical guidelines for the past few decades, and it specifies a lower carbohydrate amount for most users of automated insulin delivery systems. (LLM, conf=0.86)
Experimental — accuracy not yet measuredSustained near-normoglycemia is associated with fewer chronic complications and better quality of life in people with type 1 diabetes.
“sustained near-normoglycemia is associated with fewer chronic complications and better quality of life [1,2,3].”
From Does Resistant Starch Formed by Cooling Pasta Decrease the Postprandial Glycemic Response in Type 1 Diabetes? A Randomized Single-Blind Crossover Study (2026) · cites this paper as [3]
The “Glucose Lowering and Microvascular Complications” section reports that better glycemic status in people with type 1 diabetes is associated with fewer microvascular complications, with benefits persisting during follow-up. The paper does not establish that sustained near-normoglycemia improves quality of life; its quality-of-life discussion instead concerns the adverse effects of hypoglycemia and the benefits of hypoglycemia-awareness training. Page numbers were not available in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Most current guidelines recommend a glucose threshold below 3.9 or 4.0 mmol/L as requiring prompt treatment, especially when insulin or sulfonylurea is active in the body.
“However, most current guidelines recommend a glucose threshold of below 3.9 or 4.0 mmol/L as requiring prompt treatment, especially when insulin or sulfonylurea is active in the body [3–5].”
From Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus (2026) · cites this paper as [4]
Experimental — accuracy not yet measuredThe most common recommendation for hypoglycemia treatment is oral ingestion of 15 g of simple carbohydrates with glucose recheck in 15 min.
“The most common recommendation for hypoglycemia treatment is the oral ingestion of 15 g of simple carbohydrates, with glucose recheck in 15 min [3–5].”
From Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus (2026) · cites this paper as [4]
The reported 89% hypoglycemia event resolution with 20 g carbohydrates at 10-minute recheck in Vindedzis et al. 2012 was of very limited applicability because most current guidelines define hypoglycemia resolution as above 3.9 or 4.0 mmol/L.
“Their reported 89% hypoglycemia event resolution with 20 g of carbohydrates at 10-minute recheck [13] was of very limited applicability because most current guidelines define hypoglycemia resolution as above 3.9 or 4.0 mmol/L [3–5].”
From Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus (2026) · cites this paper as [4]
The mean initial hypoglycemia in Vindedzis et al. 2012 was 2.7 to 2.9 mmol/L, which was level 2 moderate hypoglycemia and substantially lower than the other two included studies.
“Furthermore, the mean initial hypoglycemia in this study was 2.7 to 2.9 mmol/L [13], which was level 2 moderate hypoglycemia (glucose < 3.0 mmol/l) [3–5], and was substantially lower than that of the other two included studies [11, 12].”
From Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus (2026) · cites this paper as [4]
CGM helps characterize the timing, amplitude, and frequency of excursions, and provides quantitative metrics such as TIR, time in hypoglycemia (TBR) and hyperglycemia (TAR), and indices of glycemic variability, which are increasingly used as clinically meaningful targets in diabetes management.
“CGM helps characterize the timing, amplitude, and frequency of excursions [133–139], and provides quantitative metrics such as TIR, time in hypoglycemia (TBR) and hyperglycemia (TAR), and indices of glycemic variability, which are increasingly used as clinically meaningful targets in diabetes management [140–144].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [141]
Level 1 hypoglycemia (glucose <70 mg/dL) after exogenous insulin injection was completely prevented in MTNR1B risk allele carriers under melatonin treatment compared with placebo (zero vs. seven events, P = 0.001), but not in noncarriers (two vs. five events, P = 0.20).
“In our study, level 1 hypoglycemia (glucose <70 mg/dL) (19) after exogenous insulin injection was completely prevented in carriers under melatonin treatment compared with placebo (zero vs. seven events, P = 0.001) (Fig. 4A), but not in noncarriers (two vs. five events, P = 0.20).”
From Melatonin Impairs Glucose Tolerance, First-Phase Insulin Secretion, and Insulin Feedback Inhibition; Interaction With <i>MTNR1B</i> Diabetes Risk Variant (2026) · cites this paper as [19]
Matching insulin action to the time course of glucose appearance after meals remains challenging, particularly with starchy foods.
“matching insulin action to the time course of glucose appearance after meals remains challenging, particularly with starchy foods [3,4].”
From Does Resistant Starch Formed by Cooling Pasta Decrease the Postprandial Glycemic Response in Type 1 Diabetes? A Randomized Single-Blind Crossover Study (2026) · cites this paper as [3]
The Hypoglycemia Treatment section says that added fat may slow and prolong the glycemic response to food and that insulin may remain active after recovery from hypoglycemia. It does not address the difficulty of matching insulin action to postmeal glucose appearance, particularly for starchy foods. Searches for that phrasing and for starch, insulin timing, and carbohydrate absorption found no passage establishing the claim; page numbers were not available in our copy. (LLM, conf=0.72)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667 · see citing works
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · see citing works
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888 · see citing works
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · see citing works
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · see citing works
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · see citing works
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,032 · see citing works
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518 · see citing works
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079 · see citing works
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066 · see citing works
Translating the A1C assay into estimated average glucose values
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812 · see citing works
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534 · see citing works
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471 · see citing works
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428 · see citing works
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389 · see citing works
Mortality and cardiovascular disease in type 1 and type 2 diabetes
Rawshani, A., Rawshani, A., Franzén, S., Eliasson, B., Svensson, A.-M., Miftaraj, M., McGuire, D. K., Sattar, N., Rosengren, A., & Gudbjörnsdottir, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608664 · Cited by 1,389 · see citing works
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.008 · Cited by 1,373 · see citing works
Self-citationIntensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189 · see citing works
Association of cardiometabolic multimorbidity with mortality
Di Angelantonio, E., Kaptoge, S., Wormser, D., Willeit, P., Butterworth, A. S., Bansal, N., O’Keeffe, L. M., Gao, P., Wood, A. M., Burgess, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.7008 · Cited by 1,155 · see citing works
Self-citationHypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128 · see citing works
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933 · see citing works
Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A. M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., et al. (2009) · Diabetes Care · doi:10.2337/dc08-9026 · Cited by 881 · see citing works
Gold, A. E., Macleod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.697 · Cited by 810 · see citing works
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016) · Diabetes Care · doi:10.2337/dc15-1990 · Cited by 712 · see citing works
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699 · see citing works
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes
Hayward, R. A., Reaven, P. D., Wiitala, W. L., Bahn, G. D., Reda, D. J., Ge, L., McCarren, M., Duckworth, W. C., & Emanuele, N. V. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414266 · Cited by 668 · see citing works
(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653 · see citing works
Threshold-based insulin-pump interruption for reduction of hypoglycemia
Bergenstal, R. M., Klonoff, D. C., Garg, S. K., Bode, B. W., Meredith, M., Slover, R. H., Ahmann, A. J., Welsh, J. B., Lee, S. W., & Kaufman, F. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303576 · Cited by 652 · see citing works
Clarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.517 · Cited by 651 · see citing works
Hering, B. J., Clarke, W. R., Bridges, N. D., Eggerman, T. L., Alejandro, R., Bellin, M. D., Chaloner, K., Czarniecki, C. W., Goldstein, J. S., Hunsicker, L. G., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1988 · Cited by 645 · see citing works
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes
Zoungas, S., Chalmers, J., Neal, B., Billot, L., Li, Q., Hirakawa, Y., Arima, H., Monaghan, H., Joshi, R., Colagiuri, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407963 · Cited by 626 · see citing works
Herman, W. H., Ma, Y., Uwaifo, G., Haffner, S., Kahn, S. E., Horton, E. S., Lachin, J. M., Montez, M. G., Brenneman, T., Barrett-Connor, E., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2003 · Cited by 574 · see citing works
Laiteerapong, N., Ham, S. A., Gao, Y., Moffet, H. H., Liu, J. Y., Huang, E. S., & Karter, A. J. (2019) · Diabetes Care · doi:10.2337/dc17-1144 · Cited by 574 · see citing works
Wild, D., von Maltzahn, R., Brohan, E., Christensen, T., Clauson, P., & Gonder-Frederick, L. (2007) · Patient Education and Counseling · doi:10.1016/j.pec.2007.05.003 · Cited by 545 · see citing works
Increased mortality of patients with diabetes reporting severe hypoglycemia
McCoy, R. G., Van Houten, H. K., Ziegenfuss, J. Y., Shah, N. D., Wermers, R. A., & Smith, S. A. (2012) · Diabetes Care · doi:10.2337/dc11-2054 · Cited by 539 · see citing works
Self-citationHeinemann, L., Freckmann, G., Ehrmann, D., Faber-Heinemann, G., Guerra, S., Waldenmaier, D., & Hermanns, N. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30297-6 · Cited by 522 · see citing works
Powers, M. A., Bardsley, J. K., Cypress, M., Funnell, M. M., Harms, D., Hess-Fischl, A., Hooks, B., Isaacs, D., Mandel, E. D., Maryniuk, M. D., et al. (2020) · Diabetes Care · doi:10.2337/dci20-0023 · Cited by 500 · see citing works
for the ADVANCE Collaborative group, Zoungas, S., Woodward, M., Li, Q., Cooper, M. E., Hamet, P., Harrap, S. B., Heller, S. R., Marre, M., Patel, A. A., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3369-7 · Cited by 498 · see citing works
The relationships between time in range, hyperglycemia metrics, and HbA1c
Beck, R. W., Bergenstal, R. M., Cheng, P., Kollman, C., Carlson, A. L., Johnson, M. L., & Rodbard, D. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818822496 · Cited by 479 · see citing works
The relationship of hemoglobin A1C to time-in-range in patients with diabetes
Vigersky, R. A., & McMahon, C. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0310 · Cited by 464 · see citing works
Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., Kovatchev, B. P., Messer, L. H., Parkin, C. G., Ambler-Osborn, L., et al. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac022 · Cited by 443 · see citing works
Self-citationDiverse causes of hypoglycemia-associated autonomic failure in diabetes.
Cryer, P. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031354 · Cited by 411 · see citing works
Wheeler, E., Leong, A., Liu, C.-T., Hivert, M.-F., Strawbridge, R. J., Podmore, C., Li, M., Yao, J., Sim, X., Hong, J., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002383 · Cited by 408 · see citing works
Self-citationAgiostratidou, G., Anhalt, H., Ball, D., Blonde, L., Gourgari, E., Harriman, K. N., Kowalski, A. J., Madden, P., McAuliffe-Fogarty, A. H., McElwee-Malloy, M., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1624 · Cited by 397 · see citing works
Little, R. R., Rohlfing, C. L., & Sacks, D. B. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.148841 · Cited by 365 · see citing works
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351 · see citing works
Hypoglycemia in patients with type 2 diabetes mellitus
Miller, C. D., Phillips, L. S., Ziemer, D. C., Gallina, D. L., Cook, C. B., & El-Kebbi, I. M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1653 · Cited by 341 · see citing works
Poor Cognitive Function and Risk of Severe Hypoglycemia in Type 2 Diabetes
Punthakee, Z., Miller, M. E., Launer, L. J., Williamson, J. D., Lazar, R. M., Cukierman-Yaffee, T., Seaquist, E. R., Ismail-Beigi, F., Sullivan, M. D., Lovato, L. C., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1855 · Cited by 337 · see citing works
Benoit, S. R., Zhang, Y., Geiss, L. S., Gregg, E. W., & Albright, A. L. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6712a3 · Cited by 336 · see citing works
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group (2015) · Diabetes · doi:10.2337/db14-0930 · Cited by 333 · see citing works
Bergenstal, R. M., Gal, R. L., Connor, C. G., Gubitosi-Klug, R., Kruger, D., Olson, B. A., Willi, S. M., Aleppo, G., Weinstock, R. S., Wood, J., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2596 · Cited by 306 · see citing works
Self-citationHypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes
Bremer, J. P., Jauch-Chara, K., Hallschmid, M., Schmid, S., & Schultes, B. (2009) · Diabetes Care · doi:10.2337/dc09-0114 · Cited by 298 · see citing works
Hyperglycemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetes Care · doi:10.2337/dci24-0032 · Cited by 278 · see citing works
Self-citationHopkins, D., Lawrence, I., Mansell, P., Thompson, G., Amiel, S., Campbell, M., & Heller, S. (2012) · Diabetes Care · doi:10.2337/dc11-1579 · Cited by 265 · see citing works
Selvin, E., Rawlings, A. M., Grams, M., Klein, R., Sharrett, A. R., Steffes, M., & Coresh, J. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70199-2 · Cited by 262 · see citing works
Self-citationFARSANI, S. F. F., Brodovicz, K. G., Soleymanlou, N., Marquard, J., Wissinger, E., & Maiese, B. A. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016587 · Cited by 252 · see citing works
Šoupal, J., Petruželková, L., Grunberger, G., Hásková, A., Flekač, M., Matoulek, M., Mikeš, O., Pelcl, T., Škrha, J., Horová, E., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0888 · Cited by 242 · see citing works
Tchero, H., Kangambega, P., Briatte, C., Brunet-Houdard, S., Retali, G.-R., & Rusch, E. (2019) · Telemedicine and e-Health · doi:10.1089/tmj.2018.0128 · Cited by 239 · see citing works
Blood Glucose Awareness Training (BGAT-2)
Cox, D. J., Gonder-Frederick, L., Polonsky, W., Schlundt, D., Kovatchev, B., & Clarke, W. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.637 · Cited by 235 · see citing works
Silbert, R., Salcido-Montenegro, A., Rodriguez-Gutierrez, R., Katabi, A., & McCoy, R. G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1018-0 · Cited by 229 · see citing works
Self-citationLee, A. K., Warren, B., Lee, C. J., McEvoy, J. W., Matsushita, K., Huang, E. S., Sharrett, A. R., Coresh, J., & Selvin, E. (2018) · Diabetes Care · doi:10.2337/dc17-1669 · Cited by 226 · see citing works
Self-citationNathan, D. M., McGee, P., Steffes, M. W., Lachin, J. M., & the DCCT/EDIC Research Group (2014) · Diabetes · doi:10.2337/db13-0782 · Cited by 214 · see citing works
Recurrent Diabetic Ketoacidosis in Inner-City Minority Patients
Randall, L., Begovic, J., Hudson, M., Smiley, D., Peng, L., Pitre, N., Umpierrez, D., & Umpierrez, G. (2011) · Diabetes Care · doi:10.2337/dc11-0701 · Cited by 207 · see citing works
Desai, D., Mehta, D., Mathias, P., Menon, G., & Schubart, U. K. (2018) · Diabetes Care · doi:10.2337/dc17-1379 · Cited by 206 · see citing works
Racial differences in glycemic markers: a cross-sectional analysis of community-based data
Selvin, E., Steffes, M. W., Ballantyne, C. M., Hoogeveen, R. C., Coresh, J., & Brancati, F. L. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-5-201103010-00004 · Cited by 196 · see citing works
Self-citationNine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes
The ACCORD Study Group (2016) · Diabetes Care · doi:10.2337/dc15-2283 · Cited by 193 · see citing works
Distribution of HbA1c Levels For Children and Young Adults in the U.S.
Saaddine, J. B., Fagot-Campagna, A., Rolka, D., Narayan, K. M. V., Geiss, L., Eberhardt, M., & Flegal, K. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1326 · Cited by 177 · see citing works
Zhong, V. W., Juhaeri, J., & Mayer-Davis, E. J. (2018) · Diabetes Care · doi:10.2337/dc17-1583 · Cited by 177 · see citing works
Lind, M., Pivodic, A., Svensson, A.-M., Ólafsdóttir, A. F., Wedel, H., & Ludvigsson, J. (2019) · BMJ · doi:10.1136/bmj.l4894 · Cited by 175 · see citing works
Buse, J. B., Bain, S. C., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Pratley, R. E., Linder, M., Monk Fries, T., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2251 · Cited by 175 · see citing works
Deshmukh, H., Wilmot, E. G., Gregory, R., Barnes, D., Narendran, P., Saunders, S., Furlong, N., Kamaruddin, S., Banatwalla, R., Herring, R., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0738 · Cited by 175 · see citing works
Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes
Weinstock, R. S., DuBose, S. N., Bergenstal, R. M., Chaytor, N. S., Peterson, C., Olson, B. A., Munshi, M. N., Perrin, A. J. S., Miller, K. M., Beck, R. W., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1426 · Cited by 171 · see citing works
Self-citationRisk of death following admission to a UK hospital with diabetic ketoacidosis
Gibb, F. W., Teoh, W. L., Graham, J., & Lockman, K. A. (2016) · Diabetologia · doi:10.1007/s00125-016-4034-0 · Cited by 170 · see citing works
Positioning time in range in diabetes management
Advani, A. (2020) · Diabetologia · doi:10.1007/s00125-019-05027-0 · Cited by 170 · see citing works
Determinants of Severe Hypoglycemia Complicating Type 2 Diabetes: The Fremantle Diabetes Study
Davis, T. M. E., Brown, S. G. A., Jacobs, I. G., Bulsara, M. K., Bruce, D. G., & Davis, W. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2828 · Cited by 169 · see citing works
Pasquel, F. J., Tsegka, K., Wang, H., Cardona, S., Galindo, R. J., Fayfman, M., Davis, G., Vellanki, P., Migdal, A., Gujral, U., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1168 · Cited by 161 · see citing works
Parrinello, C. M., & Selvin, E. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0548-3 · Cited by 154 · see citing works
Self-citationYeoh, E., Choudhary, P., Nwokolo, M., Ayis, S., & Amiel, S. A. (2015) · Diabetes Care · doi:10.2337/dc15-0102 · Cited by 154 · see citing works
Use of Medicare’s diabetes self-management training benefit
Strawbridge, L. M., Lloyd, J. T., Meadow, A., Riley, G. F., & Howell, B. L. (2015) · Health Education & Behavior · doi:10.1177/1090198114566271 · Cited by 152 · see citing works
Fructosamine and glycated albumin and the risk of cardiovascular outcomes and death
Selvin, E., Rawlings, A. M., Lutsey, P. L., Maruthur, N., Pankow, J. S., Steffes, M., & Coresh, J. (2015) · Circulation · doi:10.1161/circulationaha.115.015415 · Cited by 151 · see citing works
Self-citationSchopman, J. E., Geddes, J., & Frier, B. M. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.013 · Cited by 150 · see citing works
Karter, A. J., Warton, E. M., Lipska, K. J., Ralston, J. D., Moffet, H. H., Jackson, G. G., Huang, E. S., & Miller, D. R. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.3844 · Cited by 150 · see citing works
Euglycemic diabetic ketoacidosis: etiologies, evaluation, and management
Long, B., Lentz, S., Koyfman, A., & Gottlieb, M. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.02.015 · Cited by 150 · see citing works
Protein in optimal health: heart disease and type 2 diabetes
Layman, D. K., Clifton, P., Gannon, M. C., Krauss, R. M., & Nuttall, F. Q. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1571s · Cited by 142 · see citing works
McCoy, R. G., Lipska, K. J., Van Houten, H. K., & Shah, N. D. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.19099 · Cited by 141 · see citing works
Self-citationEhrmann, D., Kulzer, B., Roos, T., Haak, T., Al-Khatib, M., & Hermanns, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30042-5 · Cited by 141 · see citing works
Jacobson, A. M., Ryan, C. M., Braffett, B. H., Gubitosi-Klug, R. A., Lorenzi, G. M., Luchsinger, J. A., Trapani, V. R., Bebu, I., Chaytor, N., Hitt, S. M., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00086-3 · Cited by 138 · see citing works
Rossi, M. C., Nicolucci, A., Ozzello, A., Gentile, S., Aglialoro, A., Chiambretti, A., Baccetti, F., Gentile, F. M., Romeo, F., Lucisano, G., et al. (2019) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.04.009 · Cited by 132 · see citing works
Cariou, B., Fontaine, P., Eschwege, E., Lièvre, M., Gouet, D., Huet, D., Madani, S., Lavigne, S., & Charbonnel, B. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.10.007 · Cited by 129 · see citing works
Simplification of insulin regimen in older adults and risk of hypoglycemia
Munshi, M. N., Slyne, C., Segal, A. R., Saul, N., Lyons, C., & Weinger, K. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.2288 · Cited by 124 · see citing works
Self-citationIbrahim, M., Davies, M. J., Ahmad, E., Annabi, F. A., Eckel, R. H., Ba-Essa, E. M., El Sayed, N. A., Hess Fischl, A., Houeiss, P., Iraqi, H., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001248 · Cited by 124 · see citing works
Self-citationLee, A. K., Lee, C. J., Huang, E. S., Sharrett, A. R., Coresh, J., & Selvin, E. (2017) · Diabetes Care · doi:10.2337/dc17-0819 · Cited by 119 · see citing works
Self-citationBenoit, S. R., Hora, I., Pasquel, F. J., Gregg, E. W., Albright, A. L., & Imperatore, G. (2020) · Diabetes Care · doi:10.2337/dc19-2449 · Cited by 117 · see citing works
Elliott, J., Jacques, R. M., Kruger, J., Campbell, M. J., Amiel, S. A., Mansell, P., Speight, J., Brennan, A., & Heller, S. R. (2014) · Diabetic Medicine · doi:10.1111/dme.12441 · Cited by 112 · see citing works
Empirically establishing blood glucose targets to achieve HbA1c goals
Wei, N., Zheng, H., & Nathan, D. M. (2014) · Diabetes Care · doi:10.2337/dc13-2173 · Cited by 105 · see citing works
Mays, J. A., Jackson, K. L., Derby, T. A., Behrens, J. J., Goel, S., Molitch, M. E., Kho, A. N., & Wallia, A. (2016) · Diabetes Care · doi:10.2337/dc16-0668 · Cited by 95 · see citing works
Colacci, M., Fralick, J., Odutayo, A., & Fralick, M. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.04.006 · Cited by 94 · see citing works
Diabetes Self-Management Education Programs in Nonmetropolitan Counties — United States, 2016
Rutledge, S., Masalovich, S. E., Blacher, R. J., & SAUNDERS, M. M. (2017) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6610a1 · Cited by 90 · see citing works
Little, S. A., Speight, J., Leelarathna, L., Walkinshaw, E., Tan, H. K., Bowes, A., Lubina-Solomon, A., Chadwick, T. J., Stocken, D. D., Brennand, C., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2682 · Cited by 86 · see citing works
Basu (2017) · doi:10.1097/mlr.0000000000000728 · Cited by 77 · see citing works
Speight, J., Barendse, S. M., Singh, H., Little, S. A., Inkster, B., Frier, B. M., Heller, S. R., Rutter, M. K., & Shaw, J. A. M. (2016) · Diabetic Medicine · doi:10.1111/dme.12824 · Cited by 76 · see citing works
McCoy, R. G., Van Houten, H. K., Ziegenfuss, J. Y., Shah, N. D., Wermers, R. A., & Smith, S. A. (2013) · Endocrine Practice · doi:10.4158/ep12382.or · Cited by 76 · see citing works
Self-citationHypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas
Parekh, T. M., Raji, M., Lin, Y.-L., Tan, A., Kuo, Y.-F., & Goodwin, J. S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.3293 · Cited by 75 · see citing works
Surveillance of hypoglycemia-limitations of emergency department and hospital utilization data
Karter, A. J., Moffet, H. H., Liu, J. Y., & Lipska, K. J. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.1014 · Cited by 73 · see citing works
Ranjan, A. G., Rosenlund, S. V., Hansen, T. W., Rossing, P., Andersen, S., & Nørgaard, K. (2020) · Diabetes Care · doi:10.2337/dc20-0909 · Cited by 72 · see citing works
Khunti, K., Alsifri, S., Aronson, R., Cigrovski Berković, M., Enters-Weijnen, C., Forsén, T., Galstyan, G., Geelhoed-Duijvestijn, P., Goldfracht, M., Gydesen, H., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.05.004 · Cited by 71 · see citing works
Self-citationQuilliam, B. J., Simeone, J. C., & Ozbay, A. B. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.09.020 · Cited by 70 · see citing works
Kurani, S. S., Heien, H. C., Sangaralingham, L. R., Inselman, J. W., Shah, N. D., Golden, S. H., & McCoy, R. G. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.43597 · Cited by 70 · see citing works
Self-citationMcCoy, R. G., Galindo, R. J., Swarna, K. S., Van Houten, H. K., O’Connor, P. J., Umpierrez, G. E., & Shah, N. D. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.23471 · Cited by 69 · see citing works
Self-citationHepburn, D. A., Deary, I. J., MacLeod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1273 · Cited by 66 · see citing works
Hermanns, N., Heinemann, L., Freckmann, G., Waldenmaier, D., & Ehrmann, D. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819831695 · Cited by 66 · see citing works
Presence of Macroalbuminuria Predicts Severe Hypoglycemia in Patients With Type 2 Diabetes
Yun, J., Ko, S.-H., Ko, S.-H., Song, K., Ahn, Y., Yoon, K., Park, Y., & Ko, S. (2012) · Diabetes Care · doi:10.2337/dc12-1408 · Cited by 64 · see citing works
Riveline, J.-P., Roussel, R., Vicaut, E., de Pouvourville, G., Detournay, B., Emery, C., Levrat-Guillen, F., & Guerci, B. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0085 · Cited by 64 · see citing works
Classification of hypoglycemia awareness in people with type 1 diabetes in clinical practice
Høi-Hansen, T., Pedersen-Bjergaard, U., & Thorsteinsson, B. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2009.07.006 · Cited by 61 · see citing works
Amiel, S. A., Potts, L., Goldsmith, K., Jacob, P., Smith, E. L., Gonder-Frederick, L., Heller, S., Toschi, E., Brooks, A., Kariyawasam, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29488-x · Cited by 61 · see citing works
Bloomfield, H. E., Greer, N. L., Newman, D. R., MacDonald, R. H., Carlyle, M. H., FITZGERALD, P. J., Rutks, I. R., & Wilt, T. J. (2012) · Cited by 59 · see citing works
McTavish, L., & Wiltshire, E. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00725.x · Cited by 58 · see citing works
Fabris, C., Heinemann, L., Beck, R., Cobelli, C., & Kovatchev, B. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0236 · Cited by 58 · see citing works
Galindo, R. J., Ali, M. K., Funni, S. A., Dodge, A. B., Kurani, S. S., Shah, N. D., Umpierrez, G. E., & McCoy, R. G. (2022) · Diabetes Care · doi:10.2337/dc21-1579 · Cited by 53 · see citing works
Self-citationChoudhary, P., & Amiel, S. A. (2018) · Diabetologia · doi:10.1007/s00125-018-4566-6 · Cited by 52 · see citing works
Clinical recommendations for the use of the ambulatory glucose profile in diabetes care
Kröger, J., Reichel, A., Siegmund, T., & Ziegler, R. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819883032 · Cited by 51 · see citing works
LaManna, J., Litchman, M. L., Dickinson, J. K., Todd, A., Julius, M. M., Whitehouse, C. R., Hyer, S., & Kavookjian, J. (2019) · The Diabetes Educator · doi:10.1177/0145721719855931 · Cited by 50 · see citing works
Diabetic ketoacidosis in pregnancy: clinical risk factors, presentation, and outcomes
Dhanasekaran, M., Mohan, S., Erickson, D., Shah, P., Szymanski, L., Adrian, V., & Egan, A. M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac464 · Cited by 50 · see citing works
Wu, X.-Y., She, D.-M., Wang, F., Guo, G., Li, R., Fang, P., Li, L., Zhou, Y., Zhang, K.-Q., & Xue, Y. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00659-5 · Cited by 49 · see citing works
Leiter, L. A., Boras, D., & Woo, V. C. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.08.270 · Cited by 48 · see citing works
Bamgboye, A. O., Oni, I. O., & Collier, A. (2021) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-020-03051-3 · Cited by 48 · see citing works
Misra-Hebert, A. D., Pantalone, K. M., Ji, X., Milinovich, A., Dey, T., Chagin, K. M., Bauman, J. M., Kattan, M. W., & Zimmerman, R. S. (2018) · Diabetes Care · doi:10.2337/dc17-1834 · Cited by 46 · see citing works
Revalidation of the hypoglycemia risk stratification tool using ICD-10 codes
Karter, A. J., Warton, E. M., Moffet, H. H., Ralston, J. D., Huang, E. S., Miller, D. R., & Lipska, K. J. (2019) · Diabetes Care · doi:10.2337/dc18-2154 · Cited by 42 · see citing works
Rates of hypoglycemic and hyperglycemic emergencies among U.S. adults with diabetes, 2011–2020
McCoy, R. G., Herrin, J., Galindo, R. J., Swarna, K. S., Umpierrez, G. E., Golden, S. H., & O’Connor, P. J. (2023) · Diabetes Care · doi:10.2337/dc22-1673 · Cited by 41 · see citing works
Self-citationRecurrent hospitalizations for severe hypoglycemia and hyperglycemia among U.S. adults with diabetes
McCoy, R. G., Herrin, J., Lipska, K. J., & Shah, N. D. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.04.007 · Cited by 40 · see citing works
Self-citationAvari, P., Uduku, C., George, D., Herrero, P., Reddy, M., & Oliver, N. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0276 · Cited by 40 · see citing works
Prabhu Navis, J., Leelarathna, L., Mubita, W., Urwin, A., Rutter, M. K., Schofield, J., & Thabit, H. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01614-5 · Cited by 39 · see citing works
Mattishent, K., & Loke, Y. K. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.05.005 · Cited by 38 · see citing works
National trends in pediatric admissions for diabetic ketoacidosis, 2006–2016
Everett, E. M., Copeland, T. P., Moin, T., & Wisk, L. E. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab287 · Cited by 38 · see citing works
Chow, L. S., Zmora, R., Ma, S., Seaquist, E. R., & Schreiner, P. J. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000527 · Cited by 37 · see citing works
Hypoglycemia in older adults with type 1 diabetes
DuBose, S. N., Weinstock, R. S., Beck, R. W., Peters, A. L., Aleppo, G., Bergenstal, R. M., Rodriguez, H., Largay, J. F., Massaro, E. M., Hirsch, I. B., et al. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0268 · Cited by 36 · see citing works
Self-citationMcTavish, L., Corley, B., Weatherall, M., Wiltshire, E., & Krebs, J. D. (2018) · Diabetic Medicine · doi:10.1111/dme.13576 · Cited by 34 · see citing works
Livingstone, R., Boyle, J. G., & Petrie, J. R. (2020) · Diabetic Medicine · doi:10.1111/dme.13911 · Cited by 34 · see citing works
Desai, R., Singh, S., Syed, M. H., Dave, H., Hasnain, M., Zahid, D., Haider, M. Z., Jilani, S. M. A., Mirza, M. A., Kiran, N., et al. (2019) · Cureus · doi:10.7759/cureus.4353 · Cited by 34 · see citing works
Ghandi, K., Pieri, B., Dornhorst, A., & Hussain, S. (2021) · Diabetes Therapy · doi:10.1007/s13300-020-00965-0 · Cited by 34 · see citing works
Valenzano, M., Cibrario Bertolotti, I., Valenzano, A., & Grassi, G. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001045 · Cited by 34 · see citing works
Suico, J. G., Hövelmann, U., Zhang, S., Shen, T., Bergman, B., Sherr, J., Zijlstra, E., Frier, B. M., & Plum-Mörschel, L. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00845-7 · Cited by 32 · see citing works
Glycated albumin and risk of mortality in the US adult population
Rooney, M. R., Daya, N., Tang, O., McEvoy, J. W., Coresh, J., Christenson, R. H., & Selvin, E. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvab232 · Cited by 32 · see citing works
Self-citationA Qualitative Study of Perspectives of Older Adults on Deintensifying Diabetes Medications
Pilla, S. J., Meza, K. A., Schoenborn, N. L., Boyd, C. M., Maruthur, N. M., & Chander, G. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07828-3 · Cited by 32 · see citing works
Self-citationWatson, K. E., Dhaliwal, K. K., McMurtry, E., Donald, T., Lamont, N. C., Benterud, E., Kung, J. Y. C., Robertshaw, S., Verdin, N., Drall, K. M., et al. (2022) · Kidney Medicine · doi:10.1016/j.xkme.2022.100491 · Cited by 31 · see citing works
Thomas, M., Harjutsalo, V., Feodoroff, M., Forsblom, C., Gordin, D., & Groop, P.-H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz003 · Cited by 30 · see citing works
Sharan, R., Wiens, K., Ronksley, P. E., Hwang, S. W., Booth, G. L., Austin, P. C., Spackman, E., Bai, L., & Campbell, D. J. T. (2023) · Diabetes Care · doi:10.2337/dc23-0211 · Cited by 30 · see citing works
Glucagon prescribing and costs among U.S. Adults with diabetes, 2011–2021
Herges, J. R., Galindo, R. J., Neumiller, J. J., Heien, H. C., Umpierrez, G. E., & McCoy, R. G. (2023) · Diabetes Care · doi:10.2337/dc22-1564 · Cited by 28 · see citing works
Self-citationMatsuhisa, M., Takita, Y., Nasu, R., Nagai, Y., Ohwaki, K., & Nagashima, H. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14019 · Cited by 27 · see citing works
Glucagon use by U.S. adults with type 1 and type 2 diabetes
Kahn, P. A., Liu, S., McCoy, R., Gabbay, R. A., & Lipska, K. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107882 · Cited by 27 · see citing works
Self-citationBoggi, U., Baronti, W., Amorese, G., Pilotti, S., Occhipinti, M., Perrone, V., Marselli, L., Barsotti, M., Campani, D., Gianetti, E., et al. (2022) · Transplantation · doi:10.1097/tp.0000000000003627 · Cited by 25 · see citing works
O’Reilly, J. E., Jeyam, A., Caparrotta, T. M., Mellor, J., Hohn, A., McKeigue, P. M., McGurnaghan, S. J., Blackbourn, L. A. K., McCrimmon, R., Wild, S. H., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0689 · Cited by 25 · see citing works
Ratzki‐Leewing, A., Black, J. E., Kahkoska, A. R., Ryan, B. L., Zou, G., Klar, N., Timcevska, K., & Harris, S. B. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15268 · Cited by 24 · see citing works
Recovery from insulin-induced hypoglycemia after saccharose or glucose administration.
Georgakopoulos, K., Katsilambros, N. L., Fragaki, M., Poulopoulou, Z., Kimbouris, J., Sfikakis, P. P., & Raptis, S. A. (1990) · PubMed · Cited by 23 · see citing works
Hypoglycemia communication in primary care visits for patients with diabetes
Pilla, S. J., Park, J., Schwartz, J. L., Albert, M. C., Ephraim, P. L., Boulware, L. E., Mathioudakis, N. N., Maruthur, N. M., Beach, M. C., & Greer, R. C. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06385-x · Cited by 23 · see citing works
Self-citationSreenan, S., Andersen, M., Thorsted, B. L., Wolden, M. L., & Evans, M. (2014) · Diabetes Therapy · doi:10.1007/s13300-014-0075-x · Cited by 21 · see citing works
Shaka, H., Wani, F., El-Amir, Z., Dahiya, D. S., Singh, J., Edigin, E., Eseaton, P., & Kichloo, A. (2021) · Journal of Investigative Medicine · doi:10.1136/jim-2021-001901 · Cited by 21 · see citing works
Agrawal, L., Azad, N., Bahn, G. D., Reaven, P. D., Hayward, R. A., Reda, D. J., Emanuele, N. V., VADT Study Group, Abraira, C., Duckworth, W. C., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0891 · Cited by 20 · see citing works
McCoy, R. G., Herrin, J., Galindo, R. J., Sindhu Swarna, K., Umpierrez, G. E., Hill Golden, S., & O'Connor, P. J. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110263 · Cited by 20 · see citing works
Self-citation“Hyperglycemia aversiveness”: investigating an overlooked problem among adults with type 1 diabetes
Polonsky, W. H., Fortmann, A. L., Price, D., & Fisher, L. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107925 · Cited by 19 · see citing works
Whitehead, L., Glass, C., & Coppell, K. (2022) · Journal of Advanced Nursing · doi:10.1111/jan.15084 · Cited by 19 · see citing works
Heller, S. R., Pratley, R. E., Sinclair, A., Festa, A., Kiljański, J., Brusko, C. S., Duan, R., & Heine, R. J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13051 · Cited by 18 · see citing works
Jiang, D. H., Herrin, J., Van Houten, H. K., & McCoy, R. G. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.50602 · Cited by 17 · see citing works
Self-citationPilla, S. J., Kraschnewski, J. L., Lehman, E. B., Kong, L., Francis, E., Poger, J. M., Bryce, C. L., Maruthur, N. M., & Yeh, H.-C. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002153 · Cited by 16 · see citing works
Self-citationScheuer, S. H., Andersen, G. S., Carstensen, B., Díaz, L. J., Kosjerina, V., Lindekilde, N., Wild, S. H., Jackson, C., Pouwer, F., Benros, M. E., et al. (2024) · Diabetes Care · doi:10.2337/dc23-2394 · Cited by 16 · see citing works
Hospitalizations and inpatient mortality for hyperosmolar hyperglycemic state over a decade
Shaka, H., El-amir, Z., Wani, F., Albosta, M., Dahiya, D. S., Alabi, O., Muojieje, C. C., & Kichloo, A. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109230 · Cited by 15 · see citing works
Mortality after discharge from hospital following an episode of diabetic ketoacidosis
Shand, J. A. D., Morrow, P., & Braatvedt, G. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01953-5 · Cited by 15 · see citing works
Salabelle, C., Ly Sall, K., Eroukhmanoff, J., Franc, S., Oumbiche, H., Zrafi, W. S., Dang Duy, T. L., Valentim, C., Gaston, F., Fernandes, S., et al. (2021) · Primary Care Diabetes · doi:10.1016/j.pcd.2021.06.013 · Cited by 14 · see citing works
Au, N. H., Ratzki-Leewing, A., Zou, G., Ryan, B. L., Webster-Bogaert, S., Reichert, S. M., Brown, J. B., & Harris, S. B. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.09.004 · Cited by 14 · see citing works
Pratley, R. E., Rosenstock, J., Heller, S. R., Sinclair, A., Heine, R. J., Kiljański, J., Brusko, C. S., Duan, R., & Festa, A. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818776993 · Cited by 13 · see citing works
Lee, S., Ock, M., Kim, H., & Kim, H. (2020) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2450 · Cited by 13 · see citing works
High concurrent use of sulfonylureas and antimicrobials with drug interactions causing hypoglycemia
Pilla, S. J., Pitts, S. I., & Maruthur, N. M. (2022) · Journal of Patient Safety · doi:10.1097/pts.0000000000000739 · Cited by 12 · see citing works
Self-citationBenning, T. J., Heien, H. C., Herges, J. R., Creo, A. L., Al Nofal, A., & McCoy, R. G. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111026 · Cited by 11 · see citing works
Self-citationHenao-Carrillo, D. C., Sierra-Matamoros, F. A., Carrillo Algarra, A. J., García-Lugo, J. P., & Hernández-Zambrano, S. M. (2023) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102917 · Cited by 11 · see citing works
Pieber, T. R., Aronson, R., Christiansen, M. P., Bode, B., Junaidi, K., & Conoscenti, V. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14699 · Cited by 8 · see citing works
Farrell, K., Brunero, S., Holmes-Walker, D. J., Griffiths, R., & Salamonson, Y. (2019) · Contemporary Nurse · doi:10.1080/10376178.2019.1640620 · Cited by 7 · see citing works
Be Prepared: Sick Day Management
(2002) · Diabetes Spectrum · doi:10.2337/diaspect.15.1.54 · Cited by 6 · see citing works
Pedersen‐Bjergaard, U., Færch, L., & Thorsteinsson, B. (2022) · PubMed · Cited by 5 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [8]8. Bergenstal RM, Gal RL, Connor CG, et al.; T1D Exchange Racial Differences Study Group. Racial differences in the relationship of glucose con- centrations and hemoglobin A1c levels. Ann Intern Med 2017;167:95-102
Cited by
Sorted by citations
Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC · doi:10.1016/j.jacc.2026.03.056 · Cited by 90 · see citing works
Self-citationTumminia, A., Santoro, G. M., Oteri, V., Galeano, F., Baratta, R., Gullo, D., Frittitta, L., Sciacca, L., Moli, R. L., Piticchio, T., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112173 · Cited by 9 · see citing works
Generative Medical Event Models Improve with Scale
Waxler, S., Blazek, P., White, D., Sneider, D., Chung, K., Nagarathnam, M., Williams, P., Voeller, H., Wong, K., Swanhorst, M., et al. (2025) · arXiv · doi:10.48550/arxiv.2508.12104 · Cited by 4 · see citing works
Rogowicz-Frontczak, A., Strozyk, S., Pilacinski, S., Koperska, A., Le Thanh-Blicharz, J., Tanska, M., & Zozulinska-Ziolkiewicz, D. (2026) · Nutrients · doi:10.3390/nu18071152 · Cited by 1 · see citing works
“Improving glycemic control while minimizing hypoglycemia is a central objective because sustained near-normoglycemia is associated with fewer chronic complications and better quality of life [1–3].”
Qian, J., Stefanovski, D., Andersen, P. A. K., Vujovic, N., Kelly, L., Lepson, J., Nguyen, H., Byrne, S., Wang, W., Mandrup-Poulsen, T., et al. (2026) · Diabetes Care · doi:10.2337/dc26-0164
Diabetic gastroparesis: pathophysiology and impact on insulin timing choices
Galeano, F., Tumminia, A., Oteri, V., Le Moli, R., Piticchio, T., Scilletta, S., Di Marco, M., Di Pino, A., & Frasca, F. (2026) · Endocrine · doi:10.1007/s12020-026-04693-6
Prince, N., Lochnan, H., Shorr, R., Garon-Mailer, A., & Sun, C. J. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02144-3
“With the increased use of continuous glucose monitors in people living with T2D, continuous glucose monitors could be integrated into future study designs for hypoglycemia treatment and personalized responses to various types and quantities of simple carbohydrate treatments [4].”
- Authors
- American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., Garg, R., Khunti, K., Lal, R., Lingvay, I., Matfin, G., Pandya, N., Pekas, E. J., Pilla, S. J., Polsky, S., Segal, A. R., Seley, J. J., Selvin, E., Stanton, R. C., & Bannuru, R. R.
- ORCID
- ElSayed, Nuha A.
- McCoy, Rozalina G.
- Aleppo, Grazia
- Balapattabi, Kirthikaa
- Beverly, Elizabeth A.
- Briggs Early, Kathaleen
- Bruemmer, Dennis
- Echouffo-Tcheugui, Justin B.
- Ekhlaspour, Laya
- Garg, Rajesh
- Khunti, Kamlesh
- Lal, Rayhan
- Lingvay, Ildiko
- Pandya, Naushira
- Pekas, Elizabeth J.
- Pilla, Scott J.
- Polsky, Sarit
- Segal, Alissa R.
- Seley, Jane Jeffrie
- Selvin, Elizabeth
- Stanton, Robert C.
- Bannuru, Raveendhara R.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2024-12-09
- Volume
- 48
- Issue
- Supplement_1
- Pages
- S128-S145
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC11635034
- OpenAlex
- W4405187500
- Cited by
- 440
- References
- 179
- Citations by year
- 2026: 197 · 2025: 214 · 2024: 29
- FWCI
- 25.82
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K23DK121942)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- glycemic targets, hypoglycemia, diabetes management, glycemic control, hypoglycemia prevention, quality of care
- MeSH terms
- Glycemic Control, Blood Glucose, Diabetes Mellitus, Humans, Hypoglycemia, Practice Guidelines as Topic, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
